Sun Pharma plans to enter into Japanese markets: Report

06 Mar 2014 Evaluate

Sun Pharmaceutical Industries is reportedly planning to enter into Japanese markets, an especially lucrative market for manufacturers of low-cost drugs, through partnerships or acquisitions. The company has expanded in the last few years, mainly through acquisitions, and it is looking out for more purchases.

Mumbai-based pharmaceutical company gets more than half its sales from the United States, the world’s biggest pharmaceuticals market.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1612.00 -61.55 (-3.68%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×